Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis
Divya Bhatia, … , Oleh M. Akchurin, Mary E. Choi
Divya Bhatia, … , Oleh M. Akchurin, Mary E. Choi
Published October 22, 2019
Citation Information: JCI Insight. 2019;4(23):e132826. https://doi.org/10.1172/jci.insight.132826.
View: Text | PDF
Research Article Nephrology

Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis

  • Text
  • PDF
Abstract

Mitophagy, by maintaining mitochondrial quality control, plays a key role in maintaining kidney function and is impaired in pathologic states. Macrophages are well known for their pathogenic role in kidney fibrosis. Here, we report that PINK1/Parkin-mediated mitophagy in macrophages is compromised in experimental and human kidney fibrosis. We demonstrate downregulation of mitophagy regulators mitofusin-2 (MFN2) and Parkin downstream of PINK1 in kidney fibrosis. Loss of either Pink1 or Prkn promoted renal extracellular matrix accumulation and frequency of profibrotic/M2 macrophages. Pink1–/– or Prkn–/– BM-derived macrophages (BMDMs) showed enhanced expression of rictor. Mitochondria from TGF-β1–treated Pink1–/– BMDMs exhibited increased superoxide levels, along with reduced respiration and ATP production. In addition, mitophagy in macrophages involves PINK1-mediated phosphorylation of downstream MFN2, MFN2-facilitated recruitment of Parkin to damaged mitochondria, and macrophage-specific deletion of Mfn2 aggravates kidney fibrosis. Moreover, mitophagy regulators were downregulated in human CKD kidney and TGF-β1–treated human renal macrophages, whereas Mdivi1 treatment suppressed mitophagy mediators and promoted fibrotic response. Taken together, our study is the first to our knowledge to demonstrate that macrophage mitophagy plays a protective role against kidney fibrosis via regulating the PINK1/MFN2/Parkin-mediated pathway.

Authors

Divya Bhatia, Kuei-Pin Chung, Kiichi Nakahira, Edwin Patino, Michelle C. Rice, Lisa K. Torres, Thangamani Muthukumar, Augustine M.K. Choi, Oleh M. Akchurin, Mary E. Choi

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 Total
Citations: 11 19 27 19 19 8 1 104
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2025 (11)

Title and authors Publication Year
Autophagy and Mitophagy in Diabetic Kidney Disease—A Literature Review
Stanigut AM, Tuta L, Pana C, Alexandrescu L, Suceveanu A, Blebea NM, Vacaroiu IA
International Journal of Molecular Sciences 2025
The Role of mtDNA Mutations in Atherosclerosis: The Influence of Mitochondrial Dysfunction on Macrophage Polarization
Fedotova EI, Berezhnov AV, Popov DY, Shitikova EY, Vinokurov AY
International Journal of Molecular Sciences 2025
Histidine triad nucleotide‐binding protein 2 attenuates doxorubicin‐induced cardiotoxicity through restoring lysosomal function and promoting autophagy in mice
Jiang H, Zhang J, Jia D, Liu L, Gao J, Zhang B, Dong Z, Sun X, Yang W, Ou T, Ding S, He L, Shi Y, Hu K, Sun A, Ge J
MedComm 2025
The role of autophagy in fibrosis: Mechanisms, progression and therapeutic potential (Review)
Chen Y, Wang Z, Ma Q, Sun C
International Journal of Molecular Medicine 2025
Targeting mitochondrial dysfunction: an innovative strategy for treating renal fibrosis.
Wu YJ, Yang YR, Yan YL, Yang HY, Du JR
Molecular and cellular biochemistry 2025
Research dynamics and drug treatment of renal fibrosis from a mitochondrial perspective: a historical text data analysis based on bibliometrics.
Li X, Hu L, Hu Q, Jin H
Naunyn-Schmiedeberg's archives of pharmacology 2025
Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms, volume II
Bhatia D, Srivastava SP
Frontiers in Pharmacology 2025
Mitochondrial dysfunction: the hidden catalyst in chronic kidney disease progression
Chen J, Zhou Q, Su L, Ni L
Renal Failure 2025
Blocking TRPM4 alleviates pancreatic acinar cell damage via an NMDA receptor-dependent pathway in acute pancreatitis
Ren Y, Cui Q, Liu W, Liu H, Wang T, Lu H, Lv Y, Wu R
Theranostics 2025
Mitochondrial metabolism and cancer therapeutic innovation
Du H, Xu T, Yu S, Wu S, Zhang J
Signal Transduction and Targeted Therapy 2025
Mitochondrial subtypes in renal ischemia reperfusion injury guide delayed graft function and Long-Term graft prediction.
Hu D, Wang Z
Scientific reports 2025

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts